参考文献/References:
[1] 杜利清,白剑强,王小春,等. 同源重组修复蛋白RAD51在骨肉瘤中的表达及其意义[J].陕西医学杂志,2010,39(11):14431444.
[2] 段大鹏,秦 静,王晓庆,等. Survivin、COX2蛋白在骨肉瘤中的表达及其临床意义[J].陕西医学杂志,2015,34(10):1113.
[3] Joseph B,Kumar RV,Champaka G,et al. Biological tailoring of adjuvant radiotherapy in head and neck and oral malignancies-The potential role of p53 and eIF4E as predictive parameters[J]. Indian J Cancer,2019,56(4):330334.
[4] Luo XF,Wu XJ,Wei X,et al. LncRNA ADPGKAS1 regulated cell proliferation,invasion,migration and apoptosis via targeting miR5423p in osteosarcoma[J]. Eur Rev Med Pharmacol Sci,2019,23(20): 87518760.
[5] Li C,Ni J,Liu YX,et al. Response of miRNA223p and miRNA1495p tofolate deficiency and the differential regulation of mthfr expression in normal and cancerous human hepatocytes[J]. PLoS One,2017,12(1): e0168049.
[6] Dong HX,Wang R,Jin XY,et al. LncRNA DGCR5 promotes lung adenocarcinoma(LUAD) progression via inhibiting hsamiR223p[J]. J Cell Physiol,2018,233(5): 41264136.
[7] Zhao L,Hu K,Cao J,et al. lncRNA miat functions as a ceRNA to upregulate sirt1 by sponging miR223p in HCC cellular senescence[J]. Aging(Albany NY),2019,11(17):70987122.
[8] Xu M,Tao Z,Wang S,et al. Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemoresistance in nasopharyngeal carcinoma[J]. Biochem Biophys Res Commun,2019,512(4):902907.
[9] Cao B,Duan M,Xing Y,et al. OGlcNAc transferase activates stemlike cell potential in hepatocarcinoma through OGlcNAcylation of eukaryotic initiation factor 4E[J]. J Cell Mol Med,2019,23(4): 23842398.
[10] Lv KT,Liu Z,Feng J,et al. miR223p regulates cell proliferation and inhibits cell apoptosis through targeting the eif4ebp3 gene in human cervical squamous carcinoma cells[J]. Int J Med Sci,2018,15(2): 142152.
[11] 夏良平,曾宗渊,曾 敬,等. 喉鳞癌eIF4E及其ser209磷酸化蛋白表达[J]. 中国肿瘤,2004,13(3):171173.
[12] 胡继军,方向明,熊碧芳,等. 胃癌eIF4E和cyclin D1表达及其临床病理意义[J]. 肿瘤防治研究,2006,31(2):9799.
[13] 方海洋,李群星. eIF4E与胃癌[J]. 国际肿瘤学杂志,2009,36(4):291293.
[14] Chen J,Wu FX,Luo HL,et al. Berberine upregulates miR223p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1[J]. Am J Transl Res,2016,8(11):49324941.
[15] Wang M,Chen B,Ru Z,et al. CircRNA circITCH suppresses papillary thyroid cancer progression through miR223p/CBL/βcatenin pathway[J]. Biochem Biophys Res Commun,2018,504(1): 283288.
[16] Li X,Wang S,Chen Y,et al. miR22 targets the 3’ UTR of HMGB1 and inhibits the HMGB1associated autophagy in osteosarcoma cells during chemotherapy[J]. Tumour Biol,2014,35(6):60216028.
[17] Bersani F,Lingua MF,Morena D,et al. Deep sequencing reveals a novel miR22 regulatory network with therapeutic potential in rhabdomyosarcoma[J]. Cancer Res,2016,76(20):60956106.
相似文献/References:
[1]张 哲,程漠松,庄 鹤,等.骨肉瘤细胞中miR-215-5p和eIF2a靶向关系及临床意义[J].陕西医学杂志,2021,50(7):886.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.031]
ZHANG Zhe,CHENG Mosong,ZHUANG He,et al.Targeting relationship between miR-215-5p and eIF2a in osteosarcoma cells and its clinical significance[J].,2021,50(1):886.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.031]
[2]张素冰,高 辉,赵滨滨,等.罗哌卡因对骨肉瘤细胞增殖、侵袭及雷帕霉素靶蛋白/缺氧诱导因子1α信号通路的影响[J].陕西医学杂志,2023,52(6):666.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.007]
ZHANG Subing,GAO Hui,ZHAO Binbin,et al.Effects of ropivacaine on proliferation,invasion and mTOR/HIF-1α signaling pathway of osteosarcoma cells[J].,2023,52(1):666.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.007]
[3]李 程,关贵超,李 兵,等.骨肉瘤组织锌-α2-糖蛋白1表达及其与患者预后关系[J].陕西医学杂志,2024,(12):1709.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.025]
LI Cheng,GUAN Guichao,LI Bing,et al.Expression of AZGP1 in osteosarcoma and its relationship with prognosis[J].,2024,(1):1709.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.025]